Endometrial Cancer Trial, Recruiting NCT05647109 Sponsor: Peking University People's Hospital Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT05647109
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with either atypical endometrial hyperplasia (abnormal cells in the lining of the uterus) or early-stage, slow-growing uterine cancer (Grade 1), confirmed by a procedure called a hysteroscopy, with no sign that the cancer has grown into the muscle wall of the uterus
  • People whose scans (MRI, CT, or ultrasound) show no signs that the condition has spread outside the uterus
  • People who wish to keep their uterus or preserve their ability to have children
  • People who are willing and able to follow the treatment plan and attend regular follow-up appointments

Who may not be able to join:

  • People who have liver disease, a liver tumour (whether cancerous or not), or reduced kidney function
  • People who are pregnant or who may be pregnant
  • People who have been diagnosed with any cancer affecting the reproductive system
  • People who have had a serious condition such as a stroke or heart attack, or who have a history of blood clots
  • People who are allergic to, or cannot safely take, the medications MPA or MA (types of hormone therapy)
  • People who have other medical reasons affecting their reproductive function (confirm with trial site)
  • People who prefer to have their uterus surgically removed or who want a different type of treatment

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 8601088324383

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Peking University People's Hospital
Registry
ClinicalTrials.gov
Start date
1 September 2021
Est. completion
31 August 2025

Where this trial is recruiting

🇨🇳 China

Primary endpoints

sensitivity; accuracy

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov